Medical Device Developments的动态

???Johnson & Johnson MedTech rolls out TECNIS PureSee intraocular lens in EMEA The TECNIS PureSee features a unique, purely refractive design that offers uninterrupted, high-quality, vision with high contrast and low-light performance, comparable to a monofocal IOL. According to Johnson & Johnson MedTech, surgeons and patients make trade-off decisions when choosing an IOL, considering its clear sight, spectacles, price, and possible glares and halos. Its TECNIS PureSee IOL will address the issues and improve the overall outcomes for both patients and surgeons, said the eye health technology company. Johnson & Johnson MedTech Vision EMEA president Jacqueline Henderson said: “Cataract surgery is the number one surgery performed globally, with 28 million procedures each year. “But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia. “Today, we’re proud to launch the TECNIS PureSee IOL, giving surgeons and patients the choice of a premium IOL that combines clarity of vision and reduced visual symptoms.” Building on its purely refractive design, TECNIS PureSee IOL ensures surgeons’ ease of use in providing high tolerance to refractive error. It offers important benefits, including uninterrupted high-quality vision, with superior distance and intermediate vision, along with functional near vision for spectacle independence. Read more online:?https://lnkd.in/eWTa3fMj ?? Follow?Medical Device Developments?to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments?#johnsonandjohnson #cataractsurgery

  • ?? Johnson & Johnson MedTech rolls out TECNIS PureSee intraocular lens in EMEA



The TECNIS PureSee features a unique, purely refractive design that offers uninterrupted, high-quality, vision with high contrast and low-light performance, comparable to a monofocal IOL.



According to Johnson & Johnson MedTech, surgeons and patients make trade-off decisions when choosing an IOL, considering its clear sight, spectacles, price, and possible glares and halos.



Its TECNIS PureSee IOL will address the issues and improve the overall outcomes for both patients and surgeons, said the eye health technology company.



Johnson & Johnson MedTech Vision EMEA president Jacqueline Henderson said: “Cataract surgery is the number one surgery performed globally, with 28 million procedures each year.



“But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia.



“Today, we’re proud to launch the TECNIS PureSee IOL, giving surgeons and patient

要查看或添加评论,请登录